News and Updates
News and Updates
NEWS AND UPDATES
Stay updated with the latest healthcare news
Gadvasu releases atlas on lab diagnostic facilities
A unique feature of this calendar is the integration of QR codes. By scanning these codes, users can access a comprehensive list of diagnostic tests offered by the diagnostic laboratories of ADRC, a multi-specialty veterinary hospital of the veterinary varsity.
India’s diabetic care device market expected to grow by 4% through 2033
India’s diabetes care devices market is expected to grow at a CAGR of 4 per cent by 2033, driven by rising demand for advanced techniques and growing cases of diabetes in the country.
Apollo Health picks up controlling stake in Lucknow-based Care Diagnostics
A subsidiary of Apollo Hospitals Enterprise, Apollo Health & Lifestyle runs Apollo Clinics and Apollo Diagnostics, among others, in India and the Middle East. “It is a significant controlling stake leading to a strategic partnership between the two,” said people briefed on the transaction.
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
The company did not provide details about how many observations were made at the two sites, but said it does not "expect a material impact" from the letter to its manufacturing capacity or its sales guidance for fiscal year 2025.
Metropolis acquires Agra-based scientific pathology to expand in western UP
As part of the agreement, Metropolis Clinical Pathology will take over the laboratories and collection centers of Scientific Pathology in Agra and nearby areas through a slump sale transaction.
US FTC sues to block private equity buy of medical company
The FTC said the deal would give the combined company more than 50per cent of the market for suppliers of hydrophilic coatings used to smooth surgical and internal medical devices such as catheters.
Strand Life Sciences launches online portal to aid rare disease diagnosis
Strand Life Sciences has announced the launch of the StrandOmics Portal, an online platform designed to assist clinicians in diagnosing rare diseases more efficiently. Additionally, the company will offer genetic testing for rare diseases at a reduced cost for patients from economically disadvantaged backgrounds.
Indian rubber gloves manufacturers body alleges stockpiling of poor-quality Chinese imports to circumvent upcoming QCO
The QCO for gloves is expected to regulate the imports of gloves worth ₹600-700 crore and ensure that only BIS-certified gloves, imported or domestically manufactured, can be sold for medical use in India. The order is applicable to disposable surgical gloves, single-use medical examination gloves, and post-mortem rubber gloves, preventing bulk imports of substandard gloves and ensuring only ISI-marked gloves are permitted for hospital use.
Agilus Diagnostics and Lucence collaborate to enhance cancer diagnostics in India
As part of this partnership, Lucence’s molecular testing solutions will be incorporated into Agilus’ oncology diagnostics portfolio.
AI empowered Portable Handheld X-ray machine boost TB diagnosis
According to the Chief Medical Officer (CMO) Dr Rajat Kumar Chaurasia, "With the help of these portable X-ray machines we do at least 150 tests in a day though it has capacity for more than 250 examinations in a day within 5 seconds."
3 in 5 individuals in India die after cancer diagnosis, women disproportionately affected: Study
The Indian Council of Medical Research (ICMR) study found that India ranked third highest in cancer incidence, after China and the US, and further had 10 per cent of world's cancer-related deaths, ranking second after China.
HC told ultrasound equipment functional in 12 PHCs
The court was hearing a public interest litigation filed by activist A Veronica Mary, who highlighted the lack of ultrasound services at block-level PHCs, forcing pregnant women to travel long distances to government or private hospitals for scans. She stated that ultrasound scans are crucial for monitoring fetal development, yet many PHCs lack trained doctors to operate the equipment.
Bengaluru startup develops CRISPR based test for antibiotic resistance
Traditional diagnostic methods, such as bacterial culture and PCR-based testing, can take 24–72 hours, delaying critical treatment decisions. In contrast, PathCrisp enables direct detection from clinical samples without the need for expensive equipment or prolonged culture processes, ensuring early recognition and targeted therapy."
Wipro launches AI-enabled Ultrasound system in India
The launched technology is integrated with AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy and the device will be manufactured at PLI factory in Bengaluru.
Having x-ray to diagnose knee arthritis might make you more likely to consider potentially unnecessary surgery
Osteoarthritis arises from joint changes and the joint working extra hard to repair itself. It affects the entire joint, including the bones, cartilage, ligaments and muscles.
BMHRC gets DNA sequencer for sickle cell anemia testing
This technology allows for genetic testing to pinpoint the disease's causes and guide more effective treatments.
Maharashtra’s first robotic Nipple-Sparing Mastectomy performed in Navi Mumbai
The Robotic Nipple-Sparing Mastectomy (RNSM) with TiLoop implant reconstruction, offers a less invasive procedure with improved cosmetic outcomes. This innovative surgery was recently performed for the first time in Maharashtra at Apollo Cancer Centre, Navi Mumbai.
Medical device maker Teleflex to split lower growth units
After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while separating its urology, acute care and OEM units.
India to hold 6% share of Asia-Pacific robotic surgery market in 2024: GlobalData
India is set to hold a 6 per cent share of the Asia-Pacific robotic surgery market in 2024, driven by government support for adoption in public hospitals. While robotic-assisted surgeries enhance precision and outcomes, cost and training remain challenges.
Gerresheimer slashes revenue guidance for 2025 in half
The company now expects organic revenue growth in the range of 3 per cent to 5 per cent in 2025, down from the previous range of 7 per cent to 10 per cent. It, however, confirmed the guidance for an adjusted core profit margin of around 22 per cent.
Kerala launches Nayanamritham 2.0: AI-assisted eye screening for early detection
In addition to diabetic retinopathy (DR), Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular degeneration (AMD).
Hpv self-testing: Empowering patients for routine screening and cervical cancer elimination
Self-sampling offers numerous benefits, particularly for increasing screening coverage among underserved populations, while maintaining comparable accuracy to clinician-collected samples.
Hormone delivery via skin patch may ease prostate cancer treatment side effects
Prostate cancer cells usually require male androgen hormones, such as testosterone, to grow. Androgen deprivation therapy (ADT) employs drugs that block the androgens' "pathway" to receptor proteins on cancer cells, along with so-called luteinizing hormone-releasing hormone (LHRH) drugs that are injected or implanted to lower the testicles' production of testosterone.
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
The company, whose products range from insulin pumps to surgical robots, has been closely monitoring Trump's tariff plans due to its presence in Mexico. The country houses the device maker's third largest manufacturing facility, according to its latest annual report.
GeneDx CEO wants genetic testing for every newborn
GeneDx specializes in whole genome sequencing. That involves looking at about 20,000 genes that make up a genome, the instructions to build and sustain a human.
NIT Rourkela’s AI model enhances glucose prediction for diabetes management
NIT Rourkela researchers have developed an AI-driven model for accurate blood sugar prediction, enhancing diabetes management. Published in the IEEE Journal, the model is optimized for smartphones and insulin pumps and will undergo clinical trials in Odisha.
NephroPlus expands dialysis services in the Philippines
This expansion is part of NephroPlus’s efforts to grow internationally. Recently, the company also entered Saudi Arabia through a Joint Venture agreement. It now operates in five countries, focusing on dialysis care.
Dialysis firm FMC beats profit estimates in fourth quarter
The results were boosted by positive volume and pricing effects, as well as savings from its FME25 turnaround program and portfolio optimization plan aimed at cutting costs and helping improve its leverage ratio.
HCG uses CyberKnife S7 for Parkinson’s treatment
CyberKnife radiosurgery is a 15-minute outpatient procedure that requires no anesthesia or hospital admission, offering a non-invasive alternative to traditional surgeries for treating Parkinson’s disease and other functional neurological disorders.
FDA moves to rehire medical device staffers fired only days earlier
Three FDA staffers impacted by the decisions spoke with the AP on condition of anonymity because they planned to continue working for the agency and weren't authorised to discuss its internal procedures.
IIT Guwahati develops multi-stage clinical trial method for personalised medical care
This cutting-edge approach customises treatment regimens in real time based on each patient's individual responses during trials, resulting in highly customised and effective healthcare solutions, as per the press release.
Insulet beats quarterly profit estimates on insulin pump demand
The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external tubing typically associated with conventional pumps and eliminates the need for multiple daily injections for people with insulin-dependent diabetes.
New regional wellness center and reference laboratory opened in Thiruvananthapuram
DDRC Agilus Diagnostics has launched South Kerala’s first 24x7 regional wellness center and reference laboratory in Thiruvananthapuram, offering over 3,600 diagnostic tests and services across multiple districts.
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales
Investors have high expectations of medical device makers as they continue to benefit from healthy demand for non-urgent surgeries, especially among older Americans, over the last few quarters.
‘AI will improve diagnostic accuracy, won’t replace human intervention’
These thoughts were shared by Prof Manoj Jain, HOD pathology at SGPGIMS, during a lecture on ‘Role of Artificial Intelligence in Pathology' at the 113th Foundation Day of the department of pathology at KGMU.
J&J resumes US rollout of Varipulse heart device after investigation
The probe concluded that the Varipulse devices function as intended with no performance differences across global configurations, the company said in a statement.
UK health system to offer cutting-edge gene therapy for sickle cell disease
The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and then infusing them back into the patient.
India now manufactures CT, MRI, dialysis machines under PLI schemes
According to Aggarwal, these devices are being manufactured under the Production Linked Incentive (PLI) scheme - a govt programme under the Make-in-India initiative that offers financial incentives to businesses to boost domestic manufacturing. "We have commissioned a total 19 projects for producing 46 medical devices that are imported under the PLI scheme," he added.
India's Dr Lal Path Labs posts higher Q3 profit on steady testing demand
The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31, from 813 million rupees a year earlier, but fell short of analysts' estimate of 976.9 million rupees, according to data compiled by LSEG.
Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast
The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and older who do not use insulin, making it the first CGM available for over-the-counter sales.
NEWS AND UPDATES
Stay updated with the latest healthcare news
Gadvasu releases atlas on lab diagnostic facilities
A unique feature of this calendar is the integration of QR codes. By scanning these codes, users can access a comprehensive list of diagnostic tests offered by the diagnostic laboratories of ADRC, a multi-specialty veterinary hospital of the veterinary varsity.
India’s diabetic care device market expected to grow by 4% through 2033
India’s diabetes care devices market is expected to grow at a CAGR of 4 per cent by 2033, driven by rising demand for advanced techniques and growing cases of diabetes in the country.
Apollo Health picks up controlling stake in Lucknow-based Care Diagnostics
A subsidiary of Apollo Hospitals Enterprise, Apollo Health & Lifestyle runs Apollo Clinics and Apollo Diagnostics, among others, in India and the Middle East. “It is a significant controlling stake leading to a strategic partnership between the two,” said people briefed on the transaction.
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
The company did not provide details about how many observations were made at the two sites, but said it does not "expect a material impact" from the letter to its manufacturing capacity or its sales guidance for fiscal year 2025.
Metropolis acquires Agra-based scientific pathology to expand in western UP
As part of the agreement, Metropolis Clinical Pathology will take over the laboratories and collection centers of Scientific Pathology in Agra and nearby areas through a slump sale transaction.
US FTC sues to block private equity buy of medical company
The FTC said the deal would give the combined company more than 50per cent of the market for suppliers of hydrophilic coatings used to smooth surgical and internal medical devices such as catheters.
Strand Life Sciences launches online portal to aid rare disease diagnosis
Strand Life Sciences has announced the launch of the StrandOmics Portal, an online platform designed to assist clinicians in diagnosing rare diseases more efficiently. Additionally, the company will offer genetic testing for rare diseases at a reduced cost for patients from economically disadvantaged backgrounds.
Indian rubber gloves manufacturers body alleges stockpiling of poor-quality Chinese imports to circumvent upcoming QCO
The QCO for gloves is expected to regulate the imports of gloves worth ₹600-700 crore and ensure that only BIS-certified gloves, imported or domestically manufactured, can be sold for medical use in India. The order is applicable to disposable surgical gloves, single-use medical examination gloves, and post-mortem rubber gloves, preventing bulk imports of substandard gloves and ensuring only ISI-marked gloves are permitted for hospital use.
Agilus Diagnostics and Lucence collaborate to enhance cancer diagnostics in India
As part of this partnership, Lucence’s molecular testing solutions will be incorporated into Agilus’ oncology diagnostics portfolio.
AI empowered Portable Handheld X-ray machine boost TB diagnosis
According to the Chief Medical Officer (CMO) Dr Rajat Kumar Chaurasia, "With the help of these portable X-ray machines we do at least 150 tests in a day though it has capacity for more than 250 examinations in a day within 5 seconds."
3 in 5 individuals in India die after cancer diagnosis, women disproportionately affected: Study
The Indian Council of Medical Research (ICMR) study found that India ranked third highest in cancer incidence, after China and the US, and further had 10 per cent of world's cancer-related deaths, ranking second after China.
HC told ultrasound equipment functional in 12 PHCs
The court was hearing a public interest litigation filed by activist A Veronica Mary, who highlighted the lack of ultrasound services at block-level PHCs, forcing pregnant women to travel long distances to government or private hospitals for scans. She stated that ultrasound scans are crucial for monitoring fetal development, yet many PHCs lack trained doctors to operate the equipment.
Bengaluru startup develops CRISPR based test for antibiotic resistance
Traditional diagnostic methods, such as bacterial culture and PCR-based testing, can take 24–72 hours, delaying critical treatment decisions. In contrast, PathCrisp enables direct detection from clinical samples without the need for expensive equipment or prolonged culture processes, ensuring early recognition and targeted therapy."
Wipro launches AI-enabled Ultrasound system in India
The launched technology is integrated with AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy and the device will be manufactured at PLI factory in Bengaluru.
Having x-ray to diagnose knee arthritis might make you more likely to consider potentially unnecessary surgery
Osteoarthritis arises from joint changes and the joint working extra hard to repair itself. It affects the entire joint, including the bones, cartilage, ligaments and muscles.
BMHRC gets DNA sequencer for sickle cell anemia testing
This technology allows for genetic testing to pinpoint the disease's causes and guide more effective treatments.
Maharashtra’s first robotic Nipple-Sparing Mastectomy performed in Navi Mumbai
The Robotic Nipple-Sparing Mastectomy (RNSM) with TiLoop implant reconstruction, offers a less invasive procedure with improved cosmetic outcomes. This innovative surgery was recently performed for the first time in Maharashtra at Apollo Cancer Centre, Navi Mumbai.
Medical device maker Teleflex to split lower growth units
After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while separating its urology, acute care and OEM units.
India to hold 6% share of Asia-Pacific robotic surgery market in 2024: GlobalData
India is set to hold a 6 per cent share of the Asia-Pacific robotic surgery market in 2024, driven by government support for adoption in public hospitals. While robotic-assisted surgeries enhance precision and outcomes, cost and training remain challenges.
Gerresheimer slashes revenue guidance for 2025 in half
The company now expects organic revenue growth in the range of 3 per cent to 5 per cent in 2025, down from the previous range of 7 per cent to 10 per cent. It, however, confirmed the guidance for an adjusted core profit margin of around 22 per cent.
Kerala launches Nayanamritham 2.0: AI-assisted eye screening for early detection
In addition to diabetic retinopathy (DR), Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular degeneration (AMD).
Hpv self-testing: Empowering patients for routine screening and cervical cancer elimination
Self-sampling offers numerous benefits, particularly for increasing screening coverage among underserved populations, while maintaining comparable accuracy to clinician-collected samples.
Hormone delivery via skin patch may ease prostate cancer treatment side effects
Prostate cancer cells usually require male androgen hormones, such as testosterone, to grow. Androgen deprivation therapy (ADT) employs drugs that block the androgens' "pathway" to receptor proteins on cancer cells, along with so-called luteinizing hormone-releasing hormone (LHRH) drugs that are injected or implanted to lower the testicles' production of testosterone.
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
The company, whose products range from insulin pumps to surgical robots, has been closely monitoring Trump's tariff plans due to its presence in Mexico. The country houses the device maker's third largest manufacturing facility, according to its latest annual report.
GeneDx CEO wants genetic testing for every newborn
GeneDx specializes in whole genome sequencing. That involves looking at about 20,000 genes that make up a genome, the instructions to build and sustain a human.
NIT Rourkela’s AI model enhances glucose prediction for diabetes management
NIT Rourkela researchers have developed an AI-driven model for accurate blood sugar prediction, enhancing diabetes management. Published in the IEEE Journal, the model is optimized for smartphones and insulin pumps and will undergo clinical trials in Odisha.
NephroPlus expands dialysis services in the Philippines
This expansion is part of NephroPlus’s efforts to grow internationally. Recently, the company also entered Saudi Arabia through a Joint Venture agreement. It now operates in five countries, focusing on dialysis care.
Dialysis firm FMC beats profit estimates in fourth quarter
The results were boosted by positive volume and pricing effects, as well as savings from its FME25 turnaround program and portfolio optimization plan aimed at cutting costs and helping improve its leverage ratio.
HCG uses CyberKnife S7 for Parkinson’s treatment
CyberKnife radiosurgery is a 15-minute outpatient procedure that requires no anesthesia or hospital admission, offering a non-invasive alternative to traditional surgeries for treating Parkinson’s disease and other functional neurological disorders.
FDA moves to rehire medical device staffers fired only days earlier
Three FDA staffers impacted by the decisions spoke with the AP on condition of anonymity because they planned to continue working for the agency and weren't authorised to discuss its internal procedures.
IIT Guwahati develops multi-stage clinical trial method for personalised medical care
This cutting-edge approach customises treatment regimens in real time based on each patient's individual responses during trials, resulting in highly customised and effective healthcare solutions, as per the press release.
Insulet beats quarterly profit estimates on insulin pump demand
The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external tubing typically associated with conventional pumps and eliminates the need for multiple daily injections for people with insulin-dependent diabetes.
New regional wellness center and reference laboratory opened in Thiruvananthapuram
DDRC Agilus Diagnostics has launched South Kerala’s first 24x7 regional wellness center and reference laboratory in Thiruvananthapuram, offering over 3,600 diagnostic tests and services across multiple districts.
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales
Investors have high expectations of medical device makers as they continue to benefit from healthy demand for non-urgent surgeries, especially among older Americans, over the last few quarters.
‘AI will improve diagnostic accuracy, won’t replace human intervention’
These thoughts were shared by Prof Manoj Jain, HOD pathology at SGPGIMS, during a lecture on ‘Role of Artificial Intelligence in Pathology' at the 113th Foundation Day of the department of pathology at KGMU.
J&J resumes US rollout of Varipulse heart device after investigation
The probe concluded that the Varipulse devices function as intended with no performance differences across global configurations, the company said in a statement.
UK health system to offer cutting-edge gene therapy for sickle cell disease
The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and then infusing them back into the patient.
India now manufactures CT, MRI, dialysis machines under PLI schemes
According to Aggarwal, these devices are being manufactured under the Production Linked Incentive (PLI) scheme - a govt programme under the Make-in-India initiative that offers financial incentives to businesses to boost domestic manufacturing. "We have commissioned a total 19 projects for producing 46 medical devices that are imported under the PLI scheme," he added.
India's Dr Lal Path Labs posts higher Q3 profit on steady testing demand
The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31, from 813 million rupees a year earlier, but fell short of analysts' estimate of 976.9 million rupees, according to data compiled by LSEG.
Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast
The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and older who do not use insulin, making it the first CGM available for over-the-counter sales.